Notably, antibodies against CTL2 have been detected in 50 % of patients with autoimmune hearing loss (Kommareddi et al. 2009) indicating a prominent role of CTL2 in this and possibly other autoimmune diseases. This evidence concerns the gene SLC44A2 and autoimmune disease.